Bing Jia

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Computed Tomography

Top Venues

Molecular pharmaceutics

ACS pharmacology & translational science

Bioconjugate chemistry

ACS applied bio materials

This page only lists publications with an associated author ORCID identifier.

Publications

Zhidong Bai, Xin Xie, Chenzhen Li, Yuchen Wang, Yuanbo Wang, Huijie Li, Rui Gao, Bing Jia
Claudin18.2-Targeted SPECT/CT Imaging for Gastric Cancer: Preclinical Evaluation and Clinical Translation of the 99m Tc-Labeled Nanobody (PHG102) Radiotracer. ACS pharmacology & translational science 7 (8) (2024)
Biao Hu, Xiaopan Ma, Linqing Shi, Tianyu Liu, Liqiang Li, Meinan Yao, Chenzhen Li, Bing Jia
Noninvasive Evaluation of Tumoral PD-L1 Using a Novel 99m Tc-Labeled Nanobody Tracer with Rapid Renal Clearance. Molecular pharmaceutics 21 (4) (2024)
Mengshi Ma, Guangjie Yang, Min Zhao, Yao Liu, Xiaoguang Ge, Bing Jia, Shi Gao
Synthesis and Preliminary Study of 99m Tc-Labeled HYNIC-FAPi for Imaging of Fibroblast Activation Proteins in Tumors. Molecular pharmaceutics 21 (2) (2024)
Zhidong Bai, Xin Xie, Chenzhen Li, Yuchen Wang, Yuanbo Wang, Huijie Li, Rui Gao, Bing Jia
Claudin18.2-Targeted SPECT/CT Imaging for Gastric Cancer: Preclinical Evaluation and Clinical Translation of the 99m Tc-Labeled Nanobody (PHG102) Radiotracer. ACS pharmacology & translational science 7 (8) (2024)
Biao Hu, Xiaopan Ma, Linqing Shi, Tianyu Liu, Liqiang Li, Meinan Yao, Chenzhen Li, Bing Jia
Noninvasive Evaluation of Tumoral PD-L1 Using a Novel 99m Tc-Labeled Nanobody Tracer with Rapid Renal Clearance. Molecular pharmaceutics (2024)
Biao Hu, Xiaopan Ma, Linqing Shi, Tianyu Liu, Liqiang Li, Meinan Yao, Chenzhen Li, Bing Jia
Noninvasive Evaluation of Tumoral PD-L1 Using a Novel 99m Tc-Labeled Nanobody Tracer with Rapid Renal Clearance. Molecular pharmaceutics 21 (4) (2024)
Mengshi Ma, Guangjie Yang, Min Zhao, Yao Liu, Xiaoguang Ge, Bing Jia, Shi Gao
Synthesis and Preliminary Study of 99m Tc-Labeled HYNIC-FAPi for Imaging of Fibroblast Activation Proteins in Tumors. Molecular pharmaceutics 21 (2) (2024)
Mengshi Ma, Guangjie Yang, Min Zhao, Yao Liu, Xiaoguang Ge, Bing Jia, Shi Gao
Synthesis and Preliminary Study of 99m Tc-Labeled HYNIC-FAPi for Imaging of Fibroblast Activation Proteins in Tumors. Molecular pharmaceutics (2024)
Biao Hu, Xiaopan Ma, Linqing Shi, Tianyu Liu, Liqiang Li, Meinan Yao, Chenzhen Li, Bing Jia
Noninvasive Evaluation of Tumoral PD-L1 Using a Novel 99m Tc-Labeled Nanobody Tracer with Rapid Renal Clearance. Molecular pharmaceutics 21 (4) (2024)
Linqing Shi, Bo Chen, Tianyu Liu, Liqiang Li, Biao Hu, Chenzhen Li, Bing Jia, Fan Wang
99m Tc-CD3813: A Nanobody-Based Single Photon Emission Computed Tomography Radiotracer with Clinical Potential for Myeloma Imaging and Evaluation of CD38 Expression. Molecular pharmaceutics 19 (7) (2022)
Biao Hu, Tianyu Liu, Liqiang Li, Linqing Shi, Meinan Yao, Chenzhen Li, Xiaopan Ma, Hua Zhu, Bing Jia, Fan Wang
IgG-Binding Nanobody Capable of Prolonging Nanobody-Based Radiotracer Plasma Half-Life and Enhancing the Efficacy of Tumor-Targeted Radionuclide Therapy. Bioconjugate chemistry 33 (7) (2022)
Haitao Zhao, Hannan Gao, Chuangwei Luo, Guangjie Yang, Xiaoyu Zhao, Shi Gao, Qingjie Ma, Bing Jia, Jiyun Shi, Fan Wang
An Integrin-αvβ6/α5β1-Bitargeted Probe for the SPECT Imaging of Pancreatic Adenocarcinoma in Preclinical and Primary Clinical Studies. Bioconjugate chemistry 32 (7) (2021)
Xin Zhang, Muhua Chen, Yunwei Zhang, Yi Hou, Yue Wu, Meinan Yao, Liqiang Li, Linqing Shi, Tianyu Liu, Biao Hu, Huiyun Zhao, Xiaoda Li, Jiyun Shi, Bing Jia, Fan Wang
Monoclonal-Antibody-Templated Gold Nanoclusters for HER2 Receptors Targeted Fluorescence Imaging. ACS applied bio materials 3 (10) (2020)